Skip Nav Destination
Issues
August 2005
ISSN 0030-2414
EISSN 1423-0232
In this Issue
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2005, Vol. 68, No. 4-6
Review
Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer
Subject Area:
Oncology
Marc Salzberg; Beat Thürlimann; Hervé Bonnefois; Daniel Fink; Christoph Rochlitz; Roger von Moos; Hansjörg Senn
Oncology (2005) 68 (4-6): 293–298.
https://doi.org/10.1159/000086967
Clinical Study
A Phase II Trial of Raltitrexed (Tomudex®) in Advanced Pancreatic and Biliary Carcinoma
Subject Area:
Oncology
Eric François; M. Hebbar; J. Bennouna; D. Mayeur; H. Perrier; E. Dorval; C. Martin; H. Bourgeois; P. Barthélemy; J.Y. Douillard
Oncology (2005) 68 (4-6): 299–305.
https://doi.org/10.1159/000086968
Laboratory/Clinical Translational Research
Epithelial Syndecan-1 Expression Is Associated with Stage and Grade in Colorectal Cancer
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 306–313.
https://doi.org/10.1159/000086969
Clinical Study
Alterations of Rb Pathway Components Are Frequent Events in Patients with Oral Epithelial Dysplasia and Predict Clinical Outcome in Patients with Squamous Cell Carcinoma
Subject Area:
Oncology
Shilpi Soni; Jatinder Kaur; Anupam Kumar; Nitin Chakravarti; Meera Mathur; Sudhir Bahadur; Nootan Kumar Shukla; Suryanaryana V.S. Deo; Ranju Ralhan
Oncology (2005) 68 (4-6): 314–325.
https://doi.org/10.1159/000086970
Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer
Subject Area:
Oncology
M. Karthaus; Harald Ballo; Wolgang Abenhardt; Tilmann Steinmetz; Thomas Geer; Jörg Schimke; Dietrich Braumann; Rüdiger Behrens; Dirk Behringer; Manfred Kindler; Helmut Messmann; Hans-Peter Boeck; Roland Greinwald; Ulrich Kleeberg
Oncology (2005) 68 (4-6): 326–332.
https://doi.org/10.1159/000086971
A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer
Subject Area:
Oncology
Eun Kyung Cho; Woon Ki Lee; Seok-Ah Im; Soon Nam Lee; Se Hoon Park; Soo-Mee Bang; Dong Kyun Park; Yeon Ho Park; Dong Bok Shin; Jae Hoon Lee
Oncology (2005) 68 (4-6): 333–340.
https://doi.org/10.1159/000086972
Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR
Subject Area:
Oncology
J. Domingo-Domènech; R. Molina; T. Castel; C. Montagut; S. Puig; C. Conill; R. Martí; M. Vera; J.M. Auge; J. Malvehy; J.J. Grau; P. Gascón; B. Mellado
Oncology (2005) 68 (4-6): 341–349.
https://doi.org/10.1159/000086973
Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment
Subject Area:
Oncology
Chih-Hsin Yang; Min-Chun Chen; Ann-Lii Cheng; Chih-Hung Hsu; Kun-Huei Yeh; Yu-Chie Yu; Jacqueline Whang-Peng; Pan-Chyr Yang
Oncology (2005) 68 (4-6): 350–355.
https://doi.org/10.1159/000086974
Weekly Docetaxel in Pretreated Metastatic Breast Cancer Patients: A Phase I-II Study
Subject Area:
Oncology
Cecilia Nisticò; Francesco Cognetti; Luciano Frontini; Sandro Barni; Gianluigi Ferretti; Emilio Bria; Michele Milella; Carlo Garufi; Federica Cuppone; Barbara Vanni; Paolo Carlini; Edmondo Terzoli
Oncology (2005) 68 (4-6): 356–363.
https://doi.org/10.1159/000086975
Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer
Subject Area:
Oncology
Gianfilippo Bertelli; Ornella Garrone; Laura Bertolotti; Marcella Occelli; Serafino Conforti; Nicola Marzano; Antonio Febbraro; Paolo Carlini; Christina Liossi; Lucia Del Mastro; Robert C.F. Leonard
Oncology (2005) 68 (4-6): 364–370.
https://doi.org/10.1159/000086976
Serum Lipid Profile in Colorectal Cancer Patients with and without Synchronous Distant Metastases
Subject Area:
Oncology
Maria Notarnicola; Donato F. Altomare; Mario Correale; Eustachio Ruggieri; Benedetta D’Attoma; Anna Mastrosimini; Vito Guerra; Maria G. Caruso
Oncology (2005) 68 (4-6): 371–374.
https://doi.org/10.1159/000086977
Clinical Outcomes of 54 Pelvic Osteosarcomas Registered by Japanese Musculoskeletal Oncology Group
Subject Area:
Oncology
Toshihiro Matsuo; Takashi Sugita; Keiji Sato; Tetsuo Hotta; Hiroyuki Tsuchiya; Shoji Shimose; Tadahiko Kubo; Mitsuo Ochi
Oncology (2005) 68 (4-6): 375–381.
https://doi.org/10.1159/000086978
Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer
Subject Area:
Oncology
Alberto Chiappori; George Simon; Charles Williams; Eric Haura; Caio Rocha-Lima; Henry Wagner; Gerold Bepler; Scott Antonia
Oncology (2005) 68 (4-6): 382–390.
https://doi.org/10.1159/000086979
Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients
Subject Area:
Oncology
Giuseppe Frasci; Giuseppe D’Aiuto; Renato Thomas; Pasquale Comella; Maurizio Di Bonito; Liliana Lapenta; Massimiliano D’Aiuto; Gerardo Botti; Paolo Vallone; Vincenzo De Rosa; Roberta D’Aniello; Renato Giordano; Giuseppe Comella
Oncology (2005) 68 (4-6): 391–397.
https://doi.org/10.1159/000086980
Laboratory/Clinical Translational Research
Reduced Expression of PTEN Protein and Its Prognostic Implications in Invasive Ductal Carcinoma of the Breast
Subject Area:
Oncology
Shinichi Tsutsui; Hiroshi Inoue; Kazuhiro Yasuda; Kosuke Suzuki; Hidefumi Higashi; Shoichi Era; Masaki Mori
Oncology (2005) 68 (4-6): 398–404.
https://doi.org/10.1159/000086981
Clinical Study
Changing Quality of Life in Patients with Advanced Head and Neck Cancer after Primary Radiotherapy or Chemoradiation
Subject Area:
Oncology
Fu-Min Fang; Wen-Ling Tsai; Chih-Yen Chien; Herng-Chia Chiu; Chong-Jong Wang; Hui-Chun Chen; Ching-Yeh Hsiung
Oncology (2005) 68 (4-6): 405–413.
https://doi.org/10.1159/000086982
Laboratory Investigation
Loss of Growth Hormone Secretagogue Receptor 1a and Overexpression of Type 1b Receptor Transcripts in Human Adrenocortical Tumors
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 414–421.
https://doi.org/10.1159/000086983
Laboratory/Clinical Translational Research
Immunohistochemical Expression of Multidrug Resistance Proteins as a Predictor of Poor Response to Chemotherapy and Prognosis in Patients with Nodal Diffuse Large B-Cell Lymphoma
Subject Area:
Oncology
Masahiko Ohsawa; Yoshihiro Ikura; Hiroko Fukushima; Nobuyuki Shirai; Yoshimi Sugama; Takehisa Suekane; Michihiko Hirayama; Masayuki Hino; Makiko Ueda
Oncology (2005) 68 (4-6): 422–431.
https://doi.org/10.1159/000086984
Clinical Study
Chemoradiotherapy for Locally Advanced Pancreatic Carcinoma in Elderly Patients
Subject Area:
Oncology
Chigusa Morizane; Takuji Okusaka; Yoshinori Ito; Hideki Ueno; Masafumi Ikeda; Yoriko Takezako; Yoshikazu Kagami; Hiroshi Ikeda
Oncology (2005) 68 (4-6): 432–437.
https://doi.org/10.1159/000086985
Weekly Docetaxel and Gemcitabine as First-Line Treatment for Metastatic Breast Cancer: Results of a Multicenter Phase II Study
Subject Area:
Oncology
S. Palmeri; M. Vaglica; S. Spada; G. Filippelli; A. Farris; L. Palmeri; B. Massidda; A. Misino; F. Ferraù; G. Comella; V. Leonardi; G. Condemi; A. Mangiameli; G. De Cataldis; M.C. Macaluso; M. Cajozzo; E. Iannitto; M. Danova
Oncology (2005) 68 (4-6): 438–445.
https://doi.org/10.1159/000086986
Dose-Dense Sequential Adriamycin-Paclitaxel-Cyclophosphamide Chemotherapy Is Well Tolerated and Safe in High-Risk Early Breast Cancer
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 446–453.
https://doi.org/10.1159/000086987
Laboratory/Clinical Translational Research
Leptin Is Associated with an Increased Female Colorectal Cancer Risk: A Nested Case-Control Study in Japan
Subject Area:
Oncology
Koji Tamakoshi; Hideaki Toyoshima; Kenji Wakai; Masayo Kojima; Koji Suzuki; Yoshiyuki Watanabe; Norihiko Hayakawa; Hiroshi Yatsuya; Takaaki Kondo; Shinkan Tokudome; Shuji Hashimoto; Sadao Suzuki; Miyuki Kawado; Kotaro Ozasa; Yoshinori Ito; Akiko Tamakoshi
Oncology (2005) 68 (4-6): 454–461.
https://doi.org/10.1159/000086988
Clinical Study
MEMD/ALCAM: A Potential Marker for Tumor Invasion and Nodal Metastasis in Esophageal Squamous Cell Carcinoma
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 462–470.
https://doi.org/10.1159/000086989
Laboratory Investigation
Expression of Inducible Nitric Oxide Synthase Is Significantly Correlated with Expression of Vascular Endothelial Growth Factor and Dendritic Cell Infiltration in Patients with Advanced Gastric Carcinoma
Subject Area:
Oncology
Kenichi Yamaguchi; Hiroaki Saito; Shotaro Oro; Shigeru Tatebe; Masahide Ikeguchi; Shunichi Tsujitani
Oncology (2005) 68 (4-6): 471–478.
https://doi.org/10.1159/000086990
Clinical Study
A Phase I Study of Docetaxel, Cisplatin, 5-Fluorouracil and Leucovorin
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 479–484.
https://doi.org/10.1159/000086991
Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer
Subject Area:
Oncology
Tony S.K. Mok; Kwok Chi Lam; Conrad Lee; Li Zhang; Herman Wong; Anthony T.C. Chan; Winnie Yeo; Anthony P.C. Yim; Karen Chak; Benny Zee
Oncology (2005) 68 (4-6): 485–492.
https://doi.org/10.1159/000086992
Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer
Subject Area:
Oncology
A. Magnino; M. Gatti; P. Massucco; E. Sperti; R. Faggiuolo; D. Regge; L. Capussotti; P. Gabriele; M. Aglietta
Oncology (2005) 68 (4-6): 493–499.
https://doi.org/10.1159/000086993
Laboratory Investigation
Therapeutic Targeting of Multiple Signaling Pathways in Malignant Pleural Mesothelioma
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 500–510.
https://doi.org/10.1159/000086994
Clinical Study
Study of Tobacco Habits and Alterations in Enzymatic Antioxidant System in Oral Cancer
Subject Area:
Oncology
Beena P. Patel; Upendra M. Rawal; Pankaj M. Shah; Jayesh A. Prajapati; Rakesh M. Rawal; Tina K. Dave; Prabhudas S. Patel
Oncology (2005) 68 (4-6): 511–519.
https://doi.org/10.1159/000086995
Phase II Study of an ‘All-Oral’ Regimen of Capecitabine, Idarubicin and Cyclophosphamide for Metastatic Breast Cancer – Safety, Efficacy and Quality of Life
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 520–525.
https://doi.org/10.1159/000086996
Review
Clinical Applications of Endoscopic Ultrasound to Oncology
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 526–537.
https://doi.org/10.1159/000086997
Laboratory Investigation
Inhibitors of Epidermoid Growth Factor Receptor Suppress Cell Growth and Enhance Chemosensitivity of Nasopharyngeal Cancer Cells in vitro
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 538–547.
https://doi.org/10.1159/000086998
Analysis of Genetic Alterations Associated with DNA Diploidy, Aneuploidy and Multiploidy in Gastric Cancers
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 548–557.
https://doi.org/10.1159/000086999
Further Section
Acknowledgement to the Reviewers
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 559–560.
https://doi.org/10.1159/000087597
Author Index Vol. 68, 2005
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 561–564.
https://doi.org/10.1159/000087598
Subject Index Vol. 68, 2005
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 565–566.
https://doi.org/10.1159/000087602
Contents Vol. 68, 2005
Subject Area:
Oncology
Oncology (2005) 68 (4-6): 567–569.
https://doi.org/10.1159/000087603
